| MicroRNA therapeutics: towards a new era for the management of cancer and other diseases R Rupaimoole, FJ Slack Nature reviews Drug discovery 16 (3), 203, 2017 | 2060 | 2017 |
| Paraneoplastic thrombocytosis in ovarian cancer RL Stone, AM Nick, IA McNeish, F Balkwill, HD Han, J Bottsford-Miller, ... New England Journal of Medicine 366 (7), 610-618, 2012 | 586 | 2012 |
| Integrated analyses identify a master microRNA regulatory network for the mesenchymal subtype in serous ovarian cancer D Yang, Y Sun, L Hu, H Zheng, P Ji, CV Pecot, Y Zhao, S Reynolds, ... Cancer cell 23 (2), 186-199, 2013 | 374 | 2013 |
| miRNA deregulation in cancer cells and the tumor microenvironment R Rupaimoole, GA Calin, G Lopez-Berestein, AK Sood Cancer discovery 6 (3), 235-246, 2016 | 360 | 2016 |
| Tumour angiogenesis regulation by the miR-200 family CV Pecot, R Rupaimoole, D Yang, R Akbani, C Ivan, C Lu, S Wu, HD Han, ... Nature communications 4 (1), 1-14, 2013 | 333 | 2013 |
| Hematogenous metastasis of ovarian cancer: rethinking mode of spread S Pradeep, SW Kim, SY Wu, M Nishimura, P Chaluvally-Raghavan, ... Cancer cell 26 (1), 77-91, 2014 | 237 | 2014 |
| Metabolic shifts toward glutamine regulate tumor growth, invasion and bioenergetics in ovarian cancer L Yang, T Moss, LS Mangala, J Marini, H Zhao, S Wahlig, G Armaiz‐Pena, ... Molecular systems biology 10 (5), 728, 2014 | 215 | 2014 |
| Hypoxia promotes stem cell phenotypes and poor prognosis through epigenetic regulation of DICER T Van Den Beucken, E Koch, K Chu, R Rupaimoole, P Prickaerts, ... Nature communications 5 (1), 1-13, 2014 | 168 | 2014 |
| Hypoxia-mediated downregulation of miRNA biogenesis promotes tumour progression R Rupaimoole, SY Wu, S Pradeep, C Ivan, CV Pecot, KM Gharpure, ... Nature communications 5 (1), 1-13, 2014 | 139 | 2014 |
| Autocrine effects of tumor-derived complement MS Cho, HG Vasquez, R Rupaimoole, S Pradeep, S Wu, B Zand, HD Han, ... Cell reports 6 (6), 1085-1095, 2014 | 129 | 2014 |
| Role of focal adhesion kinase in regulating YB–1–mediated paclitaxel resistance in ovarian cancer Y Kang, W Hu, C Ivan, HJ Dalton, T Miyake, CV Pecot, B Zand, T Liu, ... Journal of the National Cancer Institute 105 (19), 1485-1495, 2013 | 119 | 2013 |
| Platelets reduce anoikis and promote metastasis by activating YAP1 signaling M Haemmerle, ML Taylor, T Gutschner, S Pradeep, MS Cho, J Sheng, ... Nature communications 8 (1), 1-15, 2017 | 99 | 2017 |
| Augmentation of response to chemotherapy by microRNA-506 through regulation of RAD51 in serous ovarian cancers G Liu, D Yang, R Rupaimoole, CV Pecot, Y Sun, LS Mangala, X Li, P Ji, ... JNCI: Journal of the National Cancer Institute 107 (7), 2015 | 99 | 2015 |
| MiR‐506 inhibits multiple targets in the epithelial‐to‐mesenchymal transition network and is associated with good prognosis in epithelial ovarian cancer Y Sun, L Hu, H Zheng, M Bagnoli, Y Guo, R Rupaimoole, ... The Journal of pathology 235 (1), 25-36, 2015 | 94 | 2015 |
| A miR-192-EGR1-HOXB9 regulatory network controls the angiogenic switch in cancer SY Wu, R Rupaimoole, F Shen, S Pradeep, CV Pecot, C Ivan, ... Nature communications 7 (1), 1-14, 2016 | 88 | 2016 |
| 2′-OMe-phosphorodithioate-modified siRNAs show increased loading into the RISC complex and enhanced anti-tumour activity SY Wu, X Yang, KM Gharpure, H Hatakeyama, M Egli, MH McGuire, ... Nature communications 5 (1), 1-12, 2014 | 88 | 2014 |
| Combining anti-miR-155 with chemotherapy for the treatment of lung cancers K Van Roosbroeck, F Fanini, T Setoyama, C Ivan, C Rodriguez-Aguayo, ... Clinical Cancer Research 23 (11), 2891-2904, 2017 | 84 | 2017 |
| Dynamin 2 along with microRNA-199a reciprocally regulate hypoxia-inducible factors and ovarian cancer metastasis HP Joshi, IV Subramanian, EK Schnettler, G Ghosh, R Rupaimoole, ... Proceedings of the National Academy of Sciences 111 (14), 5331-5336, 2014 | 82 | 2014 |
| Long noncoding RNA ceruloplasmin promotes cancer growth by altering glycolysis R Rupaimoole, J Lee, M Haemmerle, H Ling, RA Previs, S Pradeep, ... Cell reports 13 (11), 2395-2402, 2015 | 80 | 2015 |
| MicroRNA therapeutics: principles, expectations, and challenges R Rupaimoole, HD Han, G Lopez-Berestein, AK Sood Chinese journal of cancer 30 (6), 368, 2011 | 76 | 2011 |
